PHOENIX -- For chronic or subacute subdural hematoma, embolization of the middle meningeal artery (MMA) reduced recurrence, three randomized trials showed. Two trials with the Onyx liquid embolic ...

Onyx is a liquid embolic agent that is injected into an artery to occlude blood flow. In subdural hematoma, it is used to block the MMA, stopping the chronic oozing of blood into the subdural space.

The University of Alabama at Birmingham was recently named September 2023 Site of the Month by A Study of the Embolization of the Middle Meningeal Artery With ONYX™ Liquid Embolic System in the ...

(RTTNews) - Medtronic (MDT) has announced the enrollment of the first patient in its PELE (PEripheral Onyx Liquid Embolic) clinical trial, which will evaluate the safety and efficacy of the Onyx™ ...

Sometimes the darkest products (names) bring a bright spot of news to their developers, as the U.S. FDA clearance for Galway, Ireland-based Medtronic plc's Onyx liquid embolic system demonstrates.

After a hit to the head or a fall, people, especially seniors, can develop a dangerous pooling of blood and fluid between the brain's surface and it's protective covering, the dura. These "subdural ...

Micro Therapeutics Inc., an Irvine medical device maker, said Wednesday it has received federal approval to start a 106-patient trial of its onyx liquid embolic system to treat arteriovenous ...

Injection of a substance to block an artery feeding the dura (protective sack around the brain) along with surgery to remove pooled blood reduced the risk that patients will require repeat surgery ...

Earlier this month, Medtronic received a new approval from the FDA for its decades-old liquid embolic system, extending its use to treat certain kinds of internal brain bleeds. Now, Johnson & Johnson ...

Co announces it has received Humanitarian Device Exemption approval from the FDA for its Onyx HD 500 Liquid Embolic System for the treatment of intracranial aneurysms. This approval allows ev3 to ...